clinical trial · NCT06486662
A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients
Allergic AsthmaOM-85-INPlacebo
brief summary
This study will assess the safety and tolerability of OM-85-IN compared to placebo in healthy volunteers and mild asthmatic patients
started
Jun 14, 2024
primary completion
Feb 19, 2025
completion
Feb 19, 2025
last updated
Mar 3, 2025
detailed description
This study is a double-blind, randomised, placebo-controlled, single and multiple ascending doses, parallel group design study that aims to assess the safety and tolerability of OM-85-IN compared to placebo in healthy volunteers and mild asthmatic patients
official title
Safety, Tolerability and Pharmacodynamics of Single and Multiple Ascending Doses of OM-85-IN Versus Placebo in Healthy Volunteers, and Patients With Mild Allergic Asthma Using Nasal Allergen Challenge
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol